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8ABSTRACT
Glomus tumours (GT), neoplasms of the glomus body
comprise 4.5% of upper limb tumours. Seventy-five per cent
of these occur in the hand, and most are subungual (50%).
We performed a literature review and retrospective search of
histopathologically confirmed GT seen from 1995 to 2009.
Fifteen patients were identified, with an average age of 49.6
years. Eight were in the hand, 2 in the upper limb, 2 lower
limb and 3 in the ear. Eighty-six per cent presented with pain
and 50% underwent radiological investigation. Most
diagnoses followed biopsy findings. Surgical excision
resulted in a recurrence rate of 13%. The average time to
diagnosis was 3.3 years. The average duration of symptoms
was 7 to 11 years with an average of 2 to 3 consultations pre-
diagnosis. MRI remains the most useful imaging modality
(82 to 90% sensitivity). Excision biopsy is the most common
treatment. Greater awareness is needed for quicker
diagnosis.
Key Words: 
Glomus Tumour, Presentation, Imaging, Recurrence
INTRODUCTION
The glomus body is made up of glomus cells with smooth
muscle properties and hence has the ability to contract,
playing a part in thermoregulation by controlling blood flow
to the skin. Glomus bodies are highly concentrated in the
digits, palm and soles of the feet. Glomus tumour, a
neoplasm of the glomus body, is generally a benign tumour,
although malignant glomus tumour has also been
described14,15.  Glomus tumour makes up 1-4.5 % of upper
limb tumours 4, 80% of which are found in the upper
extremity, with the most common site being subungual
(50%). Glomus tumour has also been reported in almost
every other human organ 2,9,10,12,13,14.
Patients typically present with a complaint of pain, which
may remain undiagnosed for a long period of time. Grossly,
glomus tumours may present as a soft mass with deep red
purplish or bluish discoloration. The clinical triad of pinpoint
tenderness, pain and hypersensitivity to cold was present in
63-100% of patients, resulting in clinical diagnosis in 90% of
patients 1.  The average duration of symptoms was 7-11 years
with an average of 2-3 clinical consultations before the
diagnosis was made.
Magnetic resonance imaging (MRI) remains the most useful
imaging modality with 82-90% sensitivity in detecting the
growth 6,7,8. Excision biopsy is the main treatment option with
variable recurrence rate reported in the literature 1,11,17. Fifty
per cent of our cases required histopathological confirmation
before arriving at a diagnosis.
MATERIALS AND METHODS
After performing a computer database search from pathology
department records for patients with histopathological
diagnosis of glomus tumour, we retrospectively reviewed the
medical records of all patients treated at our institution
between 1995 and 2009. Eighteen records with a histological
diagnosis of glomus tumour were found and the records were
traced. Three patient folders were untraceable.
The records were reviewed for c data including: age, sex and
race, location of lesion, presentation time with respect to the
initial complaints, first clinical consultation and time of
diagnosis, presenting symptoms and clinical signs,
radiological imaging modalities employed, pathology and
staining, follow-up, outcome of treatment and complications.
RESULTS
Patient data is presented in Table I. There were 6 men and 9
women in the study population. The mean age was 49.6
years (range, 17-74 years). With respect to the Malaysian
multiracial population, the racial distribution was: 5 Malays,
5 Chinese; 4 Indians and one other. Anatomical sites of the
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tumours were as follows: hand, 8; elbow, 2; leg, 2; and
middle ear cavity, 3. The average time delay before the
patient consulted a physician after the appearance of the first
symptoms was 3.2 years. The average time taken to come to
a diagnosis after the first physician visit was 1.3 years and
the average time taken to reach a diagnosis after the onset of
symptoms was 3.3 years.
Thirteen patients (86%) presented with pain associated with
localized tenderness and 9 patients (60%) had a clinically
noticeable swelling at the site of pain. Only 4 patients (26%)
presented with an associated discoloration and 2 EBT
patients (13%) presented with tinnitus. Only 2 of the 8 digital
glomus tumour patients presented with deformity of the nail
plates. The most common clinical sign was the Love’s test
(pin point tenderness), which was present in 7 (50%) of the
patients.  One patient complained of cold intolerance. The
Hildreth, cold and transillumination tests were not employed
on any patients.
Eight patients underwent imaging procedures: MRI, 4; plain
radiograph, 1; CT angiography, 2; and ultrasonography, 1.
Imaging results helped the pathologist to make the diagnosis
of glomus tumour in 2 of the patients (one CT angiogram and
one MRI).  Otherwise, diagnosis was made on the basis of:
clinical presentation, 5; histopathological confirmation, 8;
and radiological appearance, 2.  Clinical diagnosis was made
much earlier if the patient was seen by a hand surgeon. Initial
differential diagnosis offered to patients included neuroma,
osteoarthritis, Reynaud’s phenomenon, pyogenic granuloma,
haemangioma and chronic paronychia.
Thirteen patients underwent excision biopsy while the ENT
cases underwent radical mastoidectomy and meatoplasty.
The mean duration of follow up was 18.6 months except
follow up of the ENT cases exceeded 8 years. Two patients
from the digital group (13%) had clinical recurrence for
which repeat excision was performed.
Our pathologists readily recognized the typical
characteristics of glomus tumour. Only one specimen
required histochemical staining resulting in positive actin
and negative S100 stains to confirm the diagnosis.
DISCUSSION
Glomus tumours are rare vascular tumours, which arise from
glomus bodies richly situated in the reticular dermis. These
neuromyoarterial structures play a role in thermoregulation
by regulating skin circulation 1,2,3. These benign mesenchymal
tumours are commonly found in the subungual region of
digits, and often present as tender purple coloured
subcutaneous nodules. Pain is often aggravated by
temperature changes 4. The growths are usually small (less
than one cm) and average about 3-4mm in diameter 5.
Glomus tumours represent about 1.5% of all soft tissue
tumours.
Glomus tumour has been described in almost all other organs
in the human body. In our study population, extra-digital
distribution was 47%. Five out of 7 (71%) extra-digital
glomus tumour occurred in men in contrast to 12% of digital
glomus tumour that occurred in men. The tumour occurred
all age groups, had a female to male ratio of 1.3:1 and was
equally distributed among the 3 major races in Malaysia.
The average time to diagnosis in our series was 3.3 years
with the longest being 10 years. The clinical diagnosis was
obtained much earlier in patients seen by the resident hand
surgeon and those seen at our institution later in the study
period. This reflects the importance of clinical experience
and awareness regarding the diagnosis of the condition.
Differential diagnosis considered prior to actual diagnosis
included neuroma, osteoarthritis, Reynaud’s phenomenon,
pyogenic granuloma, haemangioma and chronic paronychia.
Several clinical tests have been described to aid in the
diagnosis, including the Love’s Test7, Hildreth’s test8,
transillumination and the cold test. Love’s test pinpoints
localization of tenderness, and has a reported sensitivity and
specificity of 100% and 0%, respectively. Hildreth’s test, a
modulation of pain and tenderness, accomplished by
inflating tourniquet thus inducing ischemia, has a reported
sensitivity and specificity range of 77.4-92% and 91%-
100%. Transillumination of the digit and observation of an
opaque reddish mass with illumination has a reported
sensitivity and specificity of 23-38% and 90%, respectively.
The cold test, provocation of pain with the application of
cold water or ethyl alcohol, has a reported sensitivity and
specificity of 100% for both 8,9.
Various radiological imaging modalities have been used to
aid in the diagnosis of glomus tumour.  Half of our patients
(8/15) underwent imaging procedures which included MRI,
CT Angiogram, ultrasonography and plain radiographs.
These investigations were helpful in coming to a diagnosis in
only 2 of the study patients. On MRI, primary glomus
tumours typically appear as a dark, well-defined mass on T1
weighted images, a high signal intensity on T2 weighted
images and a bright enhancing mass on T1 post-gadolinium
fat saturation images 9,10. The specificity of MRI for glomus
tumours is estimated at 50%. This modality provides
excellent contrast between the neoplasm and normal tissue,
but it cannot differentiate between glomus tumour and solid
neoplasm using the T2-weighted image. On T1-weighted
images, a low signal accompanied by a high signal dot
indicates a nidus within a hypervascular mass, such as a
glomus tumour11,12.
Contrast-enhanced CT, used for extra-digital tumours, shows
peripheral nodular or homogenous strong enhancement in
the arterial phase and prolonged enhancement in the delayed
phase 13. Plain radiographs may show larger tumours,
however, with smaller sized tumours may appear as normal1.
Cortical thinning or bony cortical erosions can be seen with
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long standing lesions and has been present in up to 60% of
radiographs in some series10,14.
Ultrasonography with high-frequency transducers has been
found to be most useful when the tumour is less than 2 mm
in size and located in the lateral subungual area. Even when
the tumour is not palpable, the positive prediction rate with
colour Duplex sonography is 100 % 11.
Glomus tumours may be classified as solitary or multiple.
Commonly located in the fingertips, solitary tumours are
often encapsulated. The more rare multiple glomus tumours
have earlier onset, and are inherited in an autosomal
dominant manner with incomplete penetrance 3,15. Based on
its 3 typical components, i.e., glomus cells, vasculature, and
smooth muscle cells, glomus tumours may be classified as
solid glomus tumour (with poor vasculature and a scant
smooth muscle component), glomangioma (with a prominent
vascular component), or glomangiomyoma (with prominent
vascular and smooth muscle components) 5.
Histopathologically, glomus cells present with round to oval
nuclei and striking eosinophilic cytoplasm after
haematoxylin adenosine staining. Immunohistochemically,
these tumours stain positively for vimentin, neuron-specific
enolase and muscle actin, but negatively for cytokeratin and
S100 16. Malignant glomus tumours are rare. These
glomangiosarcomas are often located in the lower extremity
or deep viscera, with approximately 8 cases reported in the
hand 17. These tumour cells are strongly and diffusely positive
for vimentin, smooth muscle actin and muscle-specific actin,
and focally positive for the antiapoptotic marker bcl-2.
Metastasis is rare, and wide excision is curative with a low
recurrence rate 18.
Recommended treatment for glomus tumours is complete
surgical excision 19. In our series, the recurrence rate was
13%. True recurrence appears within weeks of surgery and
usually represents inadequate excision 20. Those that reappear
years later are believed to be a result of the development of
a new tumour near the site of the excision 21.
Multiple surgical approaches have been described in the
literature, namely the transungual, lateral subperiosteal and
the Keyser-Littler approach 14,20,22. With the transungual
approach, the nail plate is removed and an incision is made
on the nail bed, the nail bed is elevated adequately exposing
the tumor for removal and is followed by  meticulous repair.
In the lateral subperiosteal approach, an incision is made
dorsal to the mid-lateral line. Dissection is carried down to
the distal phalanx and a dorsal flap consisting of skin, nail
plate, nail bed and germinal matrix tissue is elevated in a
single layer 14. The Keyser-Littler approach is also a lateral
approach made through a high mid-lateral approach below
the paronychial fold. The distal phalangeal ligament, which
provides lateral support to the nail matrix and nail plate, is
identified and retracted. The nail matrix is then elevated over
the ligament and the dorsal cortex of the distal phalanx 22. The
transungual approach affords better exposure 20. Nail
deformities are better avoided with the lateral subperiosteal
approach. We have no experience with the lateral
subperiosteal approach. None of our patients had nail
deformities following use of the transungual approach for
removal of the tumour.
CONCLUSION
In this retrospective chart review, Glomus tumours occurred
in several organs but most were subungual (more than 50%).
Average time to diagnosis was 3.3 years. To achieve earlier
diagnosis, general practitioners and general orthopaedic
surgeons need to be more aware of small lesions with
pinpoint tenderness, as 86% of patients in the present study
presented with pain. MRI was the most useful imaging
modality and excision had a 13% recurrence rate.
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